2 TYPES OF ACQUIRED IDIOPATHIC SIDEROBLASTIC ANEMIA (AISA)

被引:75
作者
GATTERMANN, N
AUL, C
SCHNEIDER, W
机构
[1] Abteilung Für Hämatologie, Onkologie Und Klinische Immunologie, Medizinische Klinik Und Poliklinik, Universität Düsseldorf
关键词
D O I
10.1111/j.1365-2141.1990.tb02536.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
On cytological bone marrow examination we distinguished between pure sideroblastic anaemia (PSA), which is confined to dyserythropoiesis, and refractory anaemia with ring sideroblasts (RARS), which is characterized by additional dysplastic features of granulopoiesis and/or megakaryopoiesis. In a follow‐up study of 94 patients with AISA diagnosed according to FAB criteria for myelodysplastic syndromes we found a striking difference in the risk of leukaemic transformation between PSA and RARS (5 year cumulative rate 1.9%v. 48%). Overall survival was much better in PSA than in RARS (5 year cumulative chance 69%v. 19%). Infections and haemorrhages were frequent causes of death in RARS but not in PSA. Bone marrow culture studies (CFU‐GM) were performed on 10 consecutive patients with PSA and RARS, respectively. RARS patients showed grossly impaired colony growth, typical of the myelodysplastic syndromes. Patients with PSA had persisting colony formation, even if moderately decreased in frequency, with numbers of CFU‐GM being inversely correlated with the degree of erythroid hyperplasia in the bone marrow. We conclude that on cytomorphological grounds AISA can be divided into pure (dyserythropoietic) sideroblastic anaemia (PSA) and a true myelodysplastic form (RARS), with both types differing considerably in terms of survival, risk of leukaemic transformation and findings on bone marrow culture (CFU‐GM). Copyright © 1990, Wiley Blackwell. All rights reserved
引用
收藏
页码:45 / 52
页数:8
相关论文
共 42 条
[21]  
Heilmeyer L., 1966, DISTURBANCES HEME SY, P103
[22]  
HEIM S, 1986, CLIN HAEMATOL, V15, P1003
[23]  
HEIMPEL H, 1979, PRELEUKEMIA, P139
[24]  
ISCOVE NN, 1971, BLOOD-J HEMATOL, V37, P1
[25]   PRIMARY ACQUIRED SIDEROBLASTIC ANEMIA [J].
JACOBS, A .
BRITISH JOURNAL OF HAEMATOLOGY, 1986, 64 (03) :415-418
[26]   HEMATOLOGICAL FEATURES OF PRIMARY MYELODYSPLASTIC SYNDROMES (PMDS) AT INITIAL PRESENTATION - A STUDY OF 118 CASES [J].
JUNEJA, SK ;
IMBERT, M ;
JOUAULT, H ;
SCOAZEC, JY ;
SIGAUX, F ;
SULTAN, C .
JOURNAL OF CLINICAL PATHOLOGY, 1983, 36 (10) :1129-1135
[27]   NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481
[28]   UTILITY OF THE FAB CLASSIFICATION FOR MYELODYSPLASTIC SYNDROMES - INVESTIGATION OF PROGNOSTIC FACTORS IN 237 CASES [J].
KERKHOFS, H ;
HERMANS, J ;
HAAK, HL ;
LEEKSMA, CHW .
BRITISH JOURNAL OF HAEMATOLOGY, 1987, 65 (01) :73-81
[29]   PROGNOSTIC-SIGNIFICANCE OF SOME CLINICAL, MORPHOLOGICAL AND CYTOGENETIC FINDINGS IN REFRACTORY-ANEMIA (RA) AND RA WITH SIDEROBLASTS [J].
KERNDRUP, G ;
PEDERSEN, B ;
ELLEGAARD, J ;
HOKLAND, P .
BLUT, 1986, 52 (01) :35-43
[30]   CYTOGENETIC STUDIES IN 174 CONSECUTIVE PATIENTS WITH PRELEUKEMIC OR MYELODYSPLASTIC SYNDROMES [J].
KNAPP, RH ;
DEWALD, GW ;
PIERRE, RV .
MAYO CLINIC PROCEEDINGS, 1985, 60 (08) :507-516